170 related articles for article (PubMed ID: 20039208)
1. Dopamine agonist induced compulsive eating behaviour in a Parkinson's disease patient.
Khan W; Rana AQ
Pharm World Sci; 2010 Apr; 32(2):114-6. PubMed ID: 20039208
[TBL] [Abstract][Full Text] [Related]
2. Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding.
Vitale C; Trojano L; Barone P; Errico D; Agosti V; Sorrentino G; Grossi D; Santangelo G
Behav Neurol; 2013 Jan; 27(4):559-62. PubMed ID: 23242361
[TBL] [Abstract][Full Text] [Related]
3. A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist.
Salas RE; Allen RP; Earley CJ; Gamaldo CE
Sleep; 2009 May; 32(5):587-8. PubMed ID: 19480224
[No Abstract] [Full Text] [Related]
4. Neuropsychological findings in a case of punding before and after cessation of pramipexole.
Larson ER
Clin Neuropsychol; 2015; 29(1):166-78. PubMed ID: 25658417
[TBL] [Abstract][Full Text] [Related]
5. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
[TBL] [Abstract][Full Text] [Related]
6. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
[TBL] [Abstract][Full Text] [Related]
7. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
Pourcher E; Rémillard S; Cohen H
J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
[TBL] [Abstract][Full Text] [Related]
8. Compulsive eating and weight gain related to dopamine agonist use.
Nirenberg MJ; Waters C
Mov Disord; 2006 Apr; 21(4):524-9. PubMed ID: 16261618
[TBL] [Abstract][Full Text] [Related]
9. Pramipexole in psychiatry: a systematic review of the literature.
Aiken CB
J Clin Psychiatry; 2007 Aug; 68(8):1230-6. PubMed ID: 17854248
[TBL] [Abstract][Full Text] [Related]
10. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
[TBL] [Abstract][Full Text] [Related]
11. Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: a case report.
Munhoz RP; Fabiani G; Becker N; Teive HAG
J Sex Med; 2009 Apr; 6(4):1177-1180. PubMed ID: 18466265
[TBL] [Abstract][Full Text] [Related]
12. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.
Bostwick JM; Hecksel KA; Stevens SR; Bower JH; Ahlskog JE
Mayo Clin Proc; 2009 Apr; 84(4):310-6. PubMed ID: 19339647
[TBL] [Abstract][Full Text] [Related]
13. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE
Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646
[TBL] [Abstract][Full Text] [Related]
14. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
Bienfait KL; Menza M; Mark MH; Dobkin RD
J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
[TBL] [Abstract][Full Text] [Related]
15. Dopamine dysregulation syndrome in Parkinson's disease patients with unsatisfactory switching from immediate to extended release pramipexole: a further clue to incentive sensitization mechanisms?
Solla P; Cannas A; Corona M; Marrosu MG; Marrosu F
Behav Neurol; 2013 Jan; 27(4):563-6. PubMed ID: 23242362
[TBL] [Abstract][Full Text] [Related]
16. Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
Bares M; Rektorová I; Krajcovicová L; Rektor I
J Neurol; 2008 Oct; 255(10):1596; author reply 1597. PubMed ID: 18758889
[No Abstract] [Full Text] [Related]
17. Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Utsumi H; Okuma Y; Kano O; Suzuki Y; Iijima M; Tomimitsu H; Hashida H; Kubo S; Suzuki M; Nanri K; Matsumura M; Murakami H; Hattori N;
Intern Med; 2013; 52(3):325-32. PubMed ID: 23370739
[TBL] [Abstract][Full Text] [Related]
18. Hiccups in Parkinson's disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature.
Lertxundi U; Marquínez AC; Domingo-Echaburu S; Solinís MÁ; Calvo B; Del Pozo-Rodríguez A; García M; Aguirre C; Isla A
Eur J Clin Pharmacol; 2017 Sep; 73(9):1159-1164. PubMed ID: 28600702
[TBL] [Abstract][Full Text] [Related]
19. Impulse control disorders in Parkinson's disease: a retrospective analysis of 1824 patients in a 12-year period.
Gunduz A; Çiftçi T; Erbil AC; Senoglu G; Ser MH; Apaydın H
Neurol Sci; 2024 Jan; 45(1):171-175. PubMed ID: 37581771
[TBL] [Abstract][Full Text] [Related]
20. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
Bennett JP; Piercey MF
J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
